Noninflammatory cerebral vasculopathy associated with recurrent ischemic strokes.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 21075007)

Published in J Stroke Cerebrovasc Dis on November 13, 2010

Authors

James S McKinney1, Jonathan M Raser, Miguel A Guzman, William W Schlaepfer, Brett L Cucchiara, Steven R Messé, Lauren H Sansing, Scott E Kasner

Author Affiliations

1: Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. mckinnjs@umdnj.edu

Articles by these authors

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol (2007) 16.81

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke (2010) 10.66

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92

Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 7.48

A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09

Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.87

Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60

Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2014) 3.36

Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation (2002) 2.71

The safety and efficacy of thrombolysis for strokes after cardiac catheterization. J Am Coll Cardiol (2008) 2.38

PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility. J Cell Biol (2008) 2.31

Summary of evidence-based guideline: periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2013) 2.15

Comprehensive stroke centers overcome the weekend versus weekday gap in stroke treatment and mortality. Stroke (2011) 2.01

Intracranial atherosclerotic disease: an update. Ann Neurol (2009) 1.86

Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator. Circulation (2008) 1.84

Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack? Stroke (2006) 1.80

Direct interaction of focal adhesion kinase with p190RhoGEF. J Biol Chem (2003) 1.67

Still no closure on the question of PFO closure. N Engl J Med (2013) 1.64

Optical bedside monitoring of cerebral blood flow in acute ischemic stroke patients during head-of-bed manipulation. Stroke (2014) 1.62

Sulfonylurea use before stroke does not influence outcome. Stroke (2011) 1.60

Predictors of outcome in childhood intracerebral hemorrhage: a prospective consecutive cohort study. Stroke (2009) 1.56

CT-NIHSS mismatch does not correlate with MRI diffusion-perfusion mismatch. Stroke (2007) 1.55

Middle cerebral artery vasospasm: transcranial color-coded duplex sonography versus conventional nonimaging transcranial Doppler sonography. Crit Care Med (2009) 1.53

Utility of the NIH Stroke Scale as a predictor of hospital disposition. Stroke (2003) 1.51

Brain hypoxia is associated with short-term outcome after severe traumatic brain injury independently of intracranial hypertension and low cerebral perfusion pressure. Neurosurgery (2011) 1.51

Computed tomographic parameters predicting fatal outcome in large middle cerebral artery infarction. Cerebrovasc Dis (2003) 1.49

Transcranial optical monitoring of cerebrovascular hemodynamics in acute stroke patients. Opt Express (2009) 1.46

Microglial responses after ischemic stroke and intracerebral hemorrhage. Clin Dev Immunol (2013) 1.43

Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res (2010) 1.42

Headache as a risk factor for neurovascular events in pediatric brain tumor patients. Neurology (2013) 1.41

Paracetamol for stroke: easy in practice, but not in trials. Lancet Neurol (2009) 1.41

Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care (2009) 1.40

Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke (2008) 1.38

Willisian collateralization. Neurology (2004) 1.38

Positive feedback regulates switching of phosphate transporters in S. cerevisiae. Mol Cell (2007) 1.37

Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke (2010) 1.35

Carotid artery diameter in men and women and the relation to body and neck size. Stroke (2006) 1.35

Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol (2010) 1.32

CCR2+ Ly6C(hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhage. J Neurosci (2014) 1.31

Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 1.28

Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis. Stroke (2012) 1.26

Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample. J Am Heart Assoc (2013) 1.22

Cranial irradiation increases risk of stroke in pediatric brain tumor survivors. Stroke (2012) 1.18

Altered hemodynamics and regional cerebral blood flow in patients with hemodynamically significant stenoses. Stroke (2005) 1.14

ABC/XYZ estimates intracerebral hemorrhage volume as a percent of total brain volume in children. Stroke (2010) 1.13

Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial. Am Heart J (2013) 1.12

Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage. Ann Neurol (2011) 1.11

Disparities in evaluation at certified primary stroke centers: reasons for geographic and racial differences in stroke. Stroke (2013) 1.11

Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design. Int J Stroke (2010) 1.09

Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial. Stroke (2013) 1.08

Dialysis disequilibrium: another reversible posterior leukoencephalopathy syndrome? Clin Neurol Neurosurg (2003) 1.08

Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials. Stroke (2009) 1.07

American Academy of Neurology replies to Jeanne Lenzer. BMJ (2013) 1.07

Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping. J Neurol Sci (2003) 1.05

Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results. J Neuroimaging (2009) 1.04

Differential effects of aging and sex on stroke induced inflammation across the lifespan. Exp Neurol (2013) 1.03

Modified National Institutes of Health Stroke Scale can be estimated from medical records. Stroke (2003) 1.01

Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA. Stroke (2009) 1.01

Obstructive hydrocephalus from venous sinus thrombosis. Neurocrit Care (2009) 1.01

Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth disease-linked mutations in NFL and HSPB1. Hum Mol Genet (2007) 1.00

Bow hunter's syndrome caused by accessory cervical ossification: posterolateral decompression and the use of intraoperative Doppler ultrasonography. Surg Neurol (2006) 1.00

Neutrophil depletion diminishes monocyte infiltration and improves functional outcome after experimental intracerebral hemorrhage. Acta Neurochir Suppl (2011) 0.99

Who will consent to emergency treatment trials for subarachnoid hemorrhage? Acad Emerg Med (2009) 0.95

Pseudo-subarachnoid hemorrhage: report of three cases and review of the literature. Neurocrit Care (2004) 0.93

Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage. Neurocrit Care (2007) 0.92

D-dimer, magnetic resonance imaging diffusion-weighted imaging, and ABCD2 score for transient ischemic attack risk stratification. J Stroke Cerebrovasc Dis (2009) 0.92

Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort. Front Neurol (2012) 0.91

Autologous blood injection to model spontaneous intracerebral hemorrhage in mice. J Vis Exp (2011) 0.91

Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke. Stroke (2012) 0.90

Prediction of hospital disposition after thrombolysis for acute ischemic stroke using the National Institutes of Health Stroke Scale. Arch Neurol (2004) 0.90

Early impairment in consciousness predicts mortality after hemispheric ischemic stroke. Crit Care Med (2004) 0.90

The role of RNA and RNA processing in neurodegeneration. J Neurosci (2005) 0.88

Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke. Circ Cardiovasc Qual Outcomes (2012) 0.88

Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close. Circulation (2008) 0.87

Treatment of intracranial arterial stenosis. Expert Rev Neurother (2006) 0.87

Delay in the diagnosis of cerebral vein and dural sinus thrombosis: influence on outcome. Stroke (2009) 0.87

Vertebrobasilar thrombolysis with intravenous tirofiban: case report. J Thromb Thrombolysis (2002) 0.87

Hemorrhagic transformation of childhood arterial ischemic stroke. Stroke (2011) 0.86

Fatal subacute cytomegalovirus encephalitis associated with hypogammaglobulinemia and thymoma. Mayo Clin Proc (2003) 0.86

Emergency department crowding and time to care in patients with acute stroke. Stroke (2011) 0.86

Ischemic strokes after cardiac catheterization: opportune thrombolysis candidates? Arch Neurol (2006) 0.86

Gr1+ Macrophages and Dendritic Cells Dominate the Inflammatory Infiltrate 12 Hours After Experimental Intracerebral Hemorrhage. Transl Stroke Res (2012) 0.86

Impact of DTI tractography on surgical planning for resection of a pediatric pre-pontine neurenteric cyst: a case discussion and literature review. Childs Nerv Syst (2014) 0.85

Seizures do not increase in-hospital mortality after intracerebral hemorrhage in the nationwide inpatient sample. Neurocrit Care (2013) 0.84